Sign in

CIK 0001729427 · Non-accelerated filer<br>Smaller reporting company

CNS Pharmaceuticals, Inc.

Sign in to watch
Ticker
CNSP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
822318545
Phone
1-800-946-9185
Business address
2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-05-18 Fisher Michal Director Purchase +2,000 $5.00 $10K 2,000
2026-05-18 Charles Faith L. Director Purchase +7,100 $4.79 $34K 7,100
2024-02-01 Gumulka Jerzy Director Purchase +33,333 $0.30 $10K 43,006
2024-02-01 Evans Carl Anthony Director Purchase +33,333 $0.30 $10K 33,458
2024-02-01 Downs Christopher Chief Financial Officer Purchase +66,666 $0.30 $20K 103,438
2024-02-01 Climaco John M Chief Executive Officer Purchase +166,666 $0.30 $50K 215,676
2023-08-22 Downs Christopher Chief Financial Officer Purchase +27,000 $1.27 $34K 36,772
2023-08-16 Climaco John M Chief Executive Officer Purchase +2,750 $1.80 $5K 49,010
2023-04-19 Gumulka Jerzy Director Purchase +2,500 $1.70 $4K 9,673
2023-04-17 Downs Christopher Chief Financial Officer Purchase +3,100 $3.20 $10K 9,251
2023-04-12 Climaco John M Chief Executive Officer Purchase +15,000 $0.69 $10K 45,010
2023-04-10 Gumulka Jerzy Director Purchase +7,173 $0.74 $5K 7,173
2021-12-06 Downs Christopher Chief Financial Officer Purchase +5,000 $0.94 $5K 151,500
2021-11-19 Downs Christopher Chief Financial Officer Purchase +4,500 $1.15 $5K 146,500
2020-08-24 Downs Christopher Chief Financial Officer Purchase +142,000 $2.04 $290K 142,000

Page 1 of 1 · 15 trades